Technical Analysis for PRTG - Portage Biotech Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -6.95% | |
Crossed Above 20 DMA | Bullish | -6.95% | |
Pocket Pivot | Bullish Swing Setup | -6.95% | |
Inside Day | Range Contraction | -6.95% | |
Wide Bands | Range Expansion | -6.95% | |
Up 3 Days in a Row | Strength | -6.95% | |
Up 4 Days in a Row | Strength | -6.95% | |
20 DMA Resistance | Bearish | -4.51% |
Alert | Time |
---|---|
20 DMA Support | about 17 hours ago |
1.5x Volume Pace | about 18 hours ago |
Non-ADX 1,2,3,4 Bearish Retracement Entry | about 18 hours ago |
Fell Below Previous Day's Low | about 18 hours ago |
Fell Below 20 DMA | about 18 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/29/2024
Portage Biotech Inc. Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Antiviral Drug Interferon Acute Kidney Injury Biotechnology Products Natural Killer T Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.4 |
52 Week Low | 0.1999 |
Average Volume | 103,601 |
200-Day Moving Average | 1.44 |
50-Day Moving Average | 0.44 |
20-Day Moving Average | 0.29 |
10-Day Moving Average | 0.27 |
Average True Range | 0.07 |
RSI (14) | 42.86 |
ADX | 14.53 |
+DI | 20.88 |
-DI | 17.59 |
Chandelier Exit (Long, 3 ATRs) | 0.43 |
Chandelier Exit (Short, 3 ATRs) | 0.41 |
Upper Bollinger Bands | 0.43 |
Lower Bollinger Band | 0.15 |
Percent B (%b) | 0.52 |
BandWidth | 98.02 |
MACD Line | -0.05 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.0154 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.37 | ||||
Resistance 3 (R3) | 0.37 | 0.35 | 0.35 | ||
Resistance 2 (R2) | 0.35 | 0.33 | 0.35 | 0.35 | |
Resistance 1 (R1) | 0.32 | 0.32 | 0.31 | 0.32 | 0.34 |
Pivot Point | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
Support 1 (S1) | 0.27 | 0.28 | 0.26 | 0.27 | 0.24 |
Support 2 (S2) | 0.25 | 0.27 | 0.25 | 0.23 | |
Support 3 (S3) | 0.22 | 0.25 | 0.23 | ||
Support 4 (S4) | 0.22 |